SCHEMBL24637629

SCHEMBL24637629

CCC(C)(C)C(=O)CCCN1C(=O)C=CC1=O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MGLL Q99685 9/20 0.49
▸ PTGS1 P23219 7/20 0.49
▸ PTGS2 P35354 7/20 0.49
▸ FAAH O00519 5/20 0.49
▸ ALDH1A1 P00352 3/20 0.47
▸ LMNA P02545 2/20 0.47
▸ MAPT P10636 2/20 0.47
▸ NPSR1 Q6W5P4 2/20 0.47
▸ HPGD P15428 2/20 0.47
▸ HSP90AA1 P07900 1/20 0.47
▸ TLR9 Q9NR96 1/20 0.47
▸ TP53 P04637 1/20 0.47
▸ PKM P14618 1/20 0.47
▸ XBP1 P17861 1/20 0.47
▸ MAPK1 P28482 1/20 0.47
▸ HTT P42858 1/20 0.47
▸ RECQL P46063 1/20 0.47
▸ RAB9A P51151 1/20 0.47
▸ SMN1; SMN2 Q16637 1/20 0.47
▸ GPR35 Q9HC97 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25113065 0.94 PTGS1 (0.58) MGLLPTGS1PTGS2FAAHALDH1A1
SCHEMBL12330964 0.94 PTGS1 (0.58) MGLLPTGS1PTGS2FAAHALDH1A1
SCHEMBL23680466 0.84 MGLL (0.54) MGLLPTGS1PTGS2FAAHALDH1A1
SCHEMBL25603074 0.81 MGLL (0.54) MGLLPTGS1PTGS2FAAHALDH1A1
SCHEMBL24234412 0.80 MGLL (0.57) MGLLPTGS1PTGS2FAAHALDH1A1
SCHEMBL12301787 0.78 PTGS1 (0.64) MGLLPTGS1PTGS2FAAHALDH1A1
SCHEMBL24637631 0.78 PTGS1 (0.64) MGLLPTGS1PTGS2FAAHALDH1A1
SCHEMBL20911321 0.75 MGLL (0.56) MGLLPTGS1PTGS2FAAHALDH1A1
SCHEMBL17367597 0.75 MGLL (0.47) MGLLPTGS1PTGS2FAAHALDH1A1
SCHEMBL10014802 0.74 MGLL (0.60) MGLLPTGS1PTGS2FAAHALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11453870-B2 Ligase fusion proteins and application thereof GENEQUANTUM HEALTHCARE (SUZHOU) CO. LTD. (CN) 2022-09-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11453870-B2 Ligase fusion proteins and application thereof LIG1, LIG3, STUB1 MGLL 1649/4885PTGS1 4352/4885PTGS2 4409/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback